Mitigating the Mitochondrial Dysfunction and Apoptosis in Hypertrophied Left Atrium of Patients With Severe Mitral Valve Regurgitation Via Short-term Lovaza Treatment Prior to Surgery.
Active, no longer recruiting
Phase of Trial: Phase IV
Latest Information Update: 09 Sep 2013
At a glance
- Drugs Omega-3-acid ethyl esters (Primary)
- Indications Mitral valve disorders
- Focus Pharmacodynamics
- 09 Sep 2013 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 21 Jun 2011 Planned end date changed from 1 Dec 2011 to 1 Dec 2013 as reported by ClinicalTrials.gov.
- 19 Jan 2010 New trial record